Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05964361 | First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients(IL15-TransDC) | completed | Phase 1 / Phase 2 | 10 | University Hospital, AntwerpOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT01171898 | Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) | completed | Phase 1 / Phase 2 | 127 | Aragon Pharmaceuticals, Inc.INDUSTRY | 1 |
| Jun 5, 2026 |
| clinicaltrials |
| NCT01719926 | Phase I Platinum Based Chemotherapy Plus Indomethacin(PIFA) | completed | Phase 1 | 13 | UMC UtrechtOTHER | 2 | Jun 4, 2026 | clinicaltrials |
| NCT05384002 | An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum | completed | — | 14,000 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07626996 | Laparoscopic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer(LAP-OPEN) | completed | N/A | 60 | Zagazig UniversityOTHER_GOV | 1 | Jun 4, 2026 | clinicaltrials |
| NCT00951496 | Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 3 | 1,560 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | completed | Phase 3 | 5,949 | National Cancer Institute (NCI)NIH | 7 | Jun 2, 2026 | clinicaltrials |
| NCT04881045 | Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. | completed | Phase 1 | 29 | PfizerINDUSTRY | 2 | Jun 2, 2026 | clinicaltrials |
| NCT04972097 | Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue(PRESERVE) | completed | N/A | 121 | Angiodynamics, Inc.INDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05375539 | AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients | completed | Phase 1 | 12 | Milton S. Hershey Medical CenterOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT00002968 | Edrecolomab in Treating Patients With Stage II Colon Cancer | completed | Phase 3 | 2,100 | National Cancer Institute (NCI)NIH | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06259448 | Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling(PAPPEES) | completed | N/A | 173 | University Hospital, BordeauxOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06434909 | CYTALUX™for the Intraoperative Imaging of Prostate Cancer | completed | Phase 2 | 9 | Indiana UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT02048150 | Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer | completed | Phase 1 | 7 | City of Hope Medical CenterOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04345003 | MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids(ELASTUS) | completed | N/A | 40 | University Hospital, BordeauxOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06106165 | Improving Muslim Women's Uptake of Cancer Screening (IMCAN)(IMCAN) | completed | N/A | 169 | University of SunderlandOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07612865 | People's Hospital of Xinjiang Uygur Autonomous Region | completed | N/A | 160 | People's Hospital of Xinjiang Uygur Autonomous RegionOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07615998 | Young Adult Latino Testicular Cancer Survivors: a Pilot Study of Goal-Focused Emotion Regulation Therapy (GET) | completed | N/A | 35 | University of California, IrvineOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04981223 | Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging | completed | N/A | 95 | Stanford UniversityOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT05918042 | A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation(OVARD) | completed | — | 414 | AstraZenecaINDUSTRY | 1 | May 28, 2026 | clinicaltrials |
| NCT02755844 | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients(ENDOLA) | completed | Phase 1 / Phase 2 | 35 | Hospices Civils de LyonOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06010160 | Game Changers for Cervical Cancer Prevention(GC-CCP) | completed | N/A | 936 | RANDOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT03570827 | Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy | completed | Phase 2 | 53 | Mayo ClinicOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | completed | Phase 2 | 61 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03421015 | Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution(CHRU-WCMC) | completed | — | 84 | University Hospital, LilleOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT03503643 | Hemi-Gland Cryoablation for Prostate Cancer at UCLA | completed | — | 354 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04687969 | Multimodal Machine Learning Characterization of Solid Tumors | completed | — | 50 | Ciprian Catana, MD, PhDOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05044975 | Improving Sleep in Gynecologic Cancer Survivors | completed | N/A | 78 | University of ArizonaOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06102252 | Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma | completed | N/A | 60 | Sohag UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT01823562 | Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery | completed | Phase 1 | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT03430700 | Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer(PROMPT) | completed | Phase 2 | 20 | University College, LondonOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT04008095 | Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer(COLTEP) | completed | — | 40 | University Hospital, BrestOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT02397317 | Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring(SPARK) | completed | N/A | 49 | University of SydneyOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT05146297 | Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials(DISRUPT) | completed | N/A | 585 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT00911118 | Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer | completed | Phase 1 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06298305 | Artificial Intelligence & Prostate Cancer(QUANTIB) | completed | — | 200 | IRCCS San RaffaeleOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT03910660 | A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. | completed | Phase 1 / Phase 2 | 98 | BioXcel Therapeutics IncINDUSTRY | 2 | May 15, 2026 | clinicaltrials |
| NCT04019964 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | completed | Phase 2 | 8 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06255041 | Detection of Cancer in Breath Samples by Trained Detection Dogs | completed | — | 1,386 | SpotitEarlyINDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT06807398 | Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer(RF-2018-123683) | completed | — | 367 | Francesco MontorsiOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07485257 | Molecular Profiling of MRI-PSMA PET Discordance in Prostate Cancer(MP-PET-MRI) | completed | — | 30 | IRCCS San RaffaeleOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07491406 | A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance(PRS-AS) | completed | — | 185 | IRCCS San RaffaeleOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT02386137 | Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids(PERAGUS) | completed | N/A | 40 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03604757 | 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks(UROPET) | completed | Phase 2 | 22 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03644303 | Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.(TRAP) | completed | N/A | 86 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT04214210 | The DIALOGUE Study: Swiss-Korean Billateral Collaboration(DIALOGUE) | completed | N/A | 128 | University of BaselOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT04295577 | Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR(MONITOR-UK) | completed | — | 388 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT02761889 | Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer | completed | N/A | 444 | Fundacao ChampalimaudOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT04731844 | Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | completed | Phase 2 | 30 | University of RochesterOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT00959647 | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study | completed | Phase 2 | 19 | Genentech, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 8, 2026source: clinicaltrials